Catalyst Wire Dossier Catalyst Wire Dossier

Suglat

ipragliflozin · Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Suglat, covering 2012-06-05 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus [Phase 4]

See pricing